ArticleOncogene2018
RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
S-H Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this paperpooled itcites it